Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study

Subjects

Subjects :

Pulmonary and Respiratory Medicine

Details

ISSN :

22132600

Database :

OpenAIRE

Journal :

The Lancet Respiratory Medicine

Accession number :

edsair.doi...........12008d6bd607b4c235812eef7da0f736

Full Text :

https://doi.org/10.1016/s2213-2600(23)00183-2